Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
6 Prestige Biopharma announces International Non-proprietary Name for PBP1510
김** | 2022.05.31 | Votes 0 | Views 584
김** 2022.05.31 0 584
5 Prestige Biopharma Wins “Bioprocessing Excellence in SEA” at Asia-Pacific Bioprocessing Awards 2022
김** | 2022.04.01 | Votes 0 | Views 273
김** 2022.04.01 0 273
4 Prestige Biopharma Breaks Ground on R&D Center in Busan
김** | 2021.12.20 | Votes 0 | Views 292
김** 2021.12.20 0 292
3 Prestige Biopharma Invests USD 110 Million in Korean Subsidiary
김** | 2021.09.14 | Votes 0 | Views 480
김** 2021.09.14 0 480
2 Prestige Biologics to Be Listed on KOSDAQ on March 11, 2021
김** | 2021.03.10 | Votes 0 | Views 329
김** 2021.03.10 0 329
1 Prestige Biopharma Debuts on KOSPI on March 5, 2021
김** | 2021.02.08 | Votes 0 | Views 511
김** 2021.02.08 0 511

Read Prestige news >>